Comparison 3. Heparin started before versus after the surgical procedure.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
3.1 Venous thromboembolism | 1 | 100 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.11 [0.01, 2.01] |
3.2 Major bleeding | 1 | 100 | Risk Ratio (M‐H, Fixed, 95% CI) | 3.00 [0.13, 71.92] |
3.3 All‐cause mortality | 1 | 100 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |
3.4 Venous thromboembolism‐related mortality | 1 | 100 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |
3.5 Deep vein thrombosis | 1 | 100 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.11 [0.01, 2.01] |